Axa’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,164
| Closed | -$610K | – | 1152 |
|
|
2022
Q4 | $610K | Sell |
4,164
-5,148
| -55% | -$754K | ﹤0.01% | 965 |
|
|
2022
Q3 | $1.57M | Buy |
9,312
+8,880
| +2,056% | +$1.5M | 0.01% | 791 |
|
|
2022
Q2 | $49.9K | Hold |
432
| – | – | ﹤0.01% | 1101 |
|
|
2022
Q1 | $43.1K | Sell |
432
-5,488
| -93% | -$547K | ﹤0.01% | 1178 |
|
|
2021
Q4 | $921K | Buy |
+5,920
| New | +$921K | ﹤0.01% | 957 |
|
|
2021
Q1 | – | Sell |
-8,202
| Closed | -$5.46M | – | 1289 |
|
|
2020
Q4 | $5.46M | Buy |
8,202
+331
| +4% | +$220K | 0.02% | 671 |
|
|
2020
Q3 | $3.66M | Sell |
7,871
-2,477
| -24% | -$1.15M | 0.01% | 706 |
|
|
2020
Q2 | $6.05M | Sell |
10,348
-3,991
| -28% | -$2.33M | 0.02% | 556 |
|
|
2020
Q1 | $2.09M | Buy |
+14,339
| New | +$2.09M | 0.01% | 725 |
|